Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 80 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R35 GM119774
NIH
Grant: AI027757
NIH
Grant: S10OD028685
National Institutes of Health
Grant: 1S10OD028685-01
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
National Institutes of Health
Grant: 5R35GM119774-03
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation
National Institutes of Health
Grant: 3P30AI027757-36S1
University of Washington/Fred Hutch Center for AIDS Research
FWCI
7.44
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 1 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 2 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 2 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 3 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 3 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 4 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 4 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 5 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 5 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 6 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 6 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 7 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 7 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 8 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 8 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 9 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 9 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 10 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo
Additional file 10 of SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo